Leaving #ISEV2024 buzzing with inspiration! From passionate EV enthusiasts to insightful talks, this conference was "EV-cellent!” 🙌🏻👏🏼 #isev #anzsev #neuroscience

I attended the Associazione Italiana di Neuroimmunologia (#AINI ) yearly meeting in Cagliari (Sardinia). Outstanding quality of the science presented there and a fantastic opportunity to see many friends and colleagues I had not seen for many years #Neuroimmunology #Research".

Will targeting EBV infection attenuate MS disease severity? #JNIreview2024 Münz C et al.,

MiR-24-3p may reduce ACC1, and promote immunosuppressive functions of Tregs, which further help ischemic stroke injuries @LuZhang #Tregs via MiR-24-3p resorrrb #IschemicInjuries

Targeting the SUMO pathway to promote remyelination and modulate aberrant inflammation in EAE. Check out this Review lead by @AsaLjunggrenrose JNI2024

Check out 👉 the latest review about Stiff person syndrome Spectrum disorders (SPSD), prognostic markers, diagnostic criteria and phenotype. Torry Johnson & Scott"PuckFlicker"Newsome

Today I attended the Neuroimmunology Australia Annual Conference at Brisbane—an amazing experience with fantastic talks! A huge thank you to Neuroimmunology Australia for the travel award and to Piccio Lab for all the support 🙌🏻! #EVs #neuroimmunology #multiplesclerosis

Writing the discussion section of your paper

New review discussing the involvement of vaccination and infection during the rare disease of narcolepsy type 1 by ikram ayoub and @rolandliblau. Check out the review below 👇 jni-journal.com/article/S0165-…

1. Proud to share our latest manuscript, finally out! A great collab. with the Mao-Draayer lab (U of Mich/OMRF) who generated an awesome longitudinal cohort of people with MS that allowed us to identify microbiota associated with disease progression. nature.com/articles/s4159…

A little bit late to the party but I'm still excited to share my first Neuroimmunology Australia Annual Workshop at Brisbane. Thank you to the Neuroimmunology Australia for the travel award and the Best Poster presentation award. Special thanks to my supervisor Piccio Lab

Today, our PhD students presented at the bio-domain seminar series at the Charles Perkins Centre! Drishya Mainali discussed her research on extracellular vesicles (EVs) in MS, while Yvonne explored TREM2 protein expression in MS tissues. #MultipleSclerosis #ExtracellularVesicles

Soluble NCAM-1 and VCAM-1 as potential biomarkers for cognitive decline in inactive primary progressive MS. #CognitionDecline #MultipleSclerosis #PPMS #Biomarkers #Onestepforward #CarloscamaralemarroyLab

Niacin boosts macrophage phagocytosis #WeeYoungLab promoting myelin debris clearance. #Remyelination as therapeutic strategy EAE model 👇link below👇 jni-journal.com/article/S0165-…

Case report series of Down Syndrome Regression Disorder (DRSD) #DRSD known to be prone for autoimmunity demonstrate DRSD neurological symptoms improvement in response to #tofacitinib @joaquinespinosalab @ColoradoUni Check the manuscript below ⬇️ jni-journal.com/article/S0165-…

Excessive and repetitive Ampicillin treatment alter the gut-brain axis. Ampicillin induce neuroinflammation through NfL, NOS2 and GFP release. Check out 👇 the work by @TouilBoukoffa team. jni-journal.com/article/S0165-…

Post-mortem MS brain display PD1+ Granzyme B+ tissue-resident memory (Trm) T cells in MS lesions, in contact with EBV infected B cells promoting local CNS inflammation. Check out👇 this 2023 interesting study from Frenci sciencedirect.com/science/articl…

PD-L1+ B cells infected with EBV co-localize with PD-1+ EBV specific CD8 T cells in MS lesions and meninges. The PD-1/PD-L1 pathway supports local immune evasion, leading to EBV persistance in the MS CNS. Checke out 👇Frenci sciencedirect.com/science/articl….